asenapine 5.7 MG/Day 24 HR Transdermal Patch

RxCUI
2261750
RxNorm name
asenapine 5.7 MG/Day 24 HR Transdermal Patch
Display name
asenapine 5.7 MG/Day 24 HR Transdermal Patch
Full name
asenapine 5.7 MG/Day 24 HR Transdermal Patch
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SECUADOASENAPINENoven Therapeutics, LLC685eaf44-5944-4f38-afba-0a4fc0b3462b2025-01-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2261750

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
685eaf44-5944-4f38-afba-0a4fc0b3462basenapine 5.7 MG/Day 24 HR Transdermal PatchSY13These highlights do not include all the information needed to use SECUADO ® (asenapine) transdermal system safely and effectively. See full prescribing information for SECUADO ® . SECUADO ® (asenapine) transdermal system Initial U.S. Approval: 200920250130
685eaf44-5944-4f38-afba-0a4fc0b3462basenapine 5.7 MG/Day 24HR Transdermal SystemPSN13These highlights do not include all the information needed to use SECUADO ® (asenapine) transdermal system safely and effectively. See full prescribing information for SECUADO ® . SECUADO ® (asenapine) transdermal system Initial U.S. Approval: 200920250130
685eaf44-5944-4f38-afba-0a4fc0b3462b24 HR asenapine 0.238 MG/HR Transdermal SystemSCD13These highlights do not include all the information needed to use SECUADO ® (asenapine) transdermal system safely and effectively. See full prescribing information for SECUADO ® . SECUADO ® (asenapine) transdermal system Initial U.S. Approval: 200920250130